Get research updatesBipolarity involves episodes of depression and periods of elevated or irritable mood, with unusually high energy and activity.
A 27-Week Open-Label Trial To Characterize The Safety And Tolerability Of Orally Administered Ziprasidone In Children And Adolescent Subjects With Bipolar I Disorder (Manic Or Mixed), Schizophrenia Or Schizoaffective Disorder
This study has finished and is no longer accepting participants.
Multiple locations, including San DiegoExtended Duration Pharmacotherapy for Prevention of Relapse to Smoking
This study has finished and is no longer accepting participants.
Multiple locations, including BirminghamResearchers compared RG2417 and placebo to find out how the approaches affected depression symptoms in people with bipolarity type I during a depressive episode.
This study has finished and is no longer accepting participants.
Multiple locations, including BirminghamThis study evaluated the safety and effectiveness of SAGE-217 for people with bipolarity.
This study has finished and is no longer accepting participants.
Multiple locations, including Little Rock
A Novel and Practical Accelerated Low-frequency Right-sided Stimulation Protocol as a Substitute for Patients With Bipolar Depression Needing Electroconvulsive Therapy During the COVID-19 Pandemic
This study has finished and is no longer accepting participants.
In TorontoThis study has finished and is no longer accepting participants.
In PittsburghThis study has finished and is no longer accepting participants.
In DallasA Six-Week, Double-Blind, Multicenter, Placebo Controlled Study Evaluating The Efficacy And Safety Of Flexible Doses Of Oral Ziprasidone As Add-On, Adjunctive Therapy With Lithium, Valproate Or Lamotrigine In Bipolar I Depression
This study has finished and is no longer accepting participants.
Multiple locations, including ChandlerAccelerated Intermittent Theta Burst Stimulation for the Treatment of Non-suicidal Self-injury in Patients With Unipolar Depression and Bipolar Depression: a Sham-controlled Study
Current recruitment status is unconfirmed.
In ChangshaA Multi-Center, Open-Label, Safety and Tolerability Study of Flexible-Dose Oral Aripiprazole (2 Mg-30 mg) in the Treatment of Adolescent Patients With Schizophrenia and Child and Adolescent Patients With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features
This study has finished and is no longer accepting participants.
Multiple locations, including BirminghamComparing the Safety and Effectiveness of a Mood Stabilizing Medication, an Antidepressant Medication, and a Combination of Both Medications to Treat Symptoms of Bipolar Type II Depression
This study has finished and is no longer accepting participants.
Multiple locations, including Los AngelesA Randomized, Double-Blind, Placebo Controlled Exploratory Study of Augmentation of Seroquel XR With Pramipexole Dihydrochloride for Bipolar Depression
This study has finished and is no longer accepting participants.
Multiple locations, including San DiegoWe gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.